Correlation Between Entrada Therapeutics and Privia Health

Can any of the company-specific risk be diversified away by investing in both Entrada Therapeutics and Privia Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entrada Therapeutics and Privia Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entrada Therapeutics and Privia Health Group, you can compare the effects of market volatilities on Entrada Therapeutics and Privia Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entrada Therapeutics with a short position of Privia Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entrada Therapeutics and Privia Health.

Diversification Opportunities for Entrada Therapeutics and Privia Health

0.78

Correlation Coefficient

Entrada Therapeutics  Privia Health

Poor diversification

The 3 months correlation between Entrada and Privia is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Entrada Therapeutics and Privia Health Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Privia Health Group and Entrada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entrada Therapeutics are associated (or correlated) with Privia Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Privia Health Group has no effect on the direction of Entrada Therapeutics i.e., Entrada Therapeutics and Privia Health go up and down completely randomly.

Pair Corralation between Entrada Therapeutics and Privia Health

Given the investment horizon of 90 days Entrada Therapeutics is expected to generate 1.46 times more return on investment than Privia Health. However, Entrada Therapeutics is 1.46 times more volatile than Privia Health Group. It trades about 0.03 of its potential returns per unit of risk. Privia Health Group is currently generating about 0.01 per unit of risk. If you would invest  1,537  in Entrada Therapeutics on September 24, 2024 and sell it today you would earn a total of  222.00  from holding Entrada Therapeutics or generate 14.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Entrada Therapeutics  vs.  Privia Health Group

Entrada Therapeutics

Risk-Adjusted Performance

6 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Privia Health Group

Risk-Adjusted Performance

5 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Privia Health Group are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Privia Health may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Entrada Therapeutics and Privia Health

The main advantage of trading using opposite Entrada Therapeutics and Privia Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entrada Therapeutics position performs unexpectedly, Privia Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Privia Health will offset losses from the drop in Privia Health's long position.

The idea behind Entrada Therapeutics and Privia Health Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.